U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06836427) titled 'CMTS0929 for Clostridioides Difficile Infection' on Feb. 14.
Brief Summary: This is a prospective, open-label, single-arm study to explore the safety and the efficacy of CMTS0929 for patients with Clostridioides difficile infection (CDI).
Study Start Date: Feb. 20
Study Type: INTERVENTIONAL
Condition:
Clostridioides Difficile Infection
Intervention:
BIOLOGICAL: CMTS0929
CMTS0929 is defined as suspension from washed microbiota.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: The Second Hospital of Nanjing Medical University
Information provided by (Responsible Party): Faming Zhang, The Second Hospital of Nanjing Medical Uni...